Takeda gets DCGI approval for its dengue vaccine QDENGA (TAK-003)
QDENGA, now approved in 43 countries, including India, is designed to protect against all four dengue virus serotypes
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dengue
WHO prequalifies new dengue vaccine
WHO recommends the use of TAK-003 in children aged 6–16 years in settings with high dengue burden and transmission intensity
We have attempted to make the dengue vaccine more affordable than other innovative vaccines
Gary Dubin, President, Global Vaccine Business Unit, Takeda, and Dion Warren, Head of Multi-Country Organization, India &…
Takeda partner with Biological E. to accelerate access to dengue vaccine
The partnership will build upon existing manufacturing capacity for the vaccine at Takeda’s facility in Singen, Germany and…
IIT Mandi, DBT-inStem researchers discover biochemistry behind resilience of dengue mosquito eggs
This research lays the foundation for innovative mosquito control methods, potentially reducing disease transmission
Chinese, US scientists identify bacterial secreted proteins that can inactivate coronavirus
This can provide a future avenue for the development of broad-spectrum antiviral drugs that might reduce the clinical burden…
WHO’s SAGE recommends use of Sanofi Pasteur’s dengue vaccine in endemic countries
It also recognised strong public health benefit to be gained by introduction of Dengvaxia, dengue vaccine
Indian scientists develop breakthrough dengue drug
The project was jointly undertaken by DBT, ICGEB and Ranbaxy Research Laboratory and employed Ayurveda in devising the drug
In a…
Dengvaxia dengue vaccine approved in the Philippines
The vaccine administered in three doses over a one-year period will help prevent the disease caused by all four dengue types in…
DBT to strengthen international linkages for research on infectious diseases and vaccine development
Initiates partnership proposal for research on human infectious diseases with Infect-ERA NET
A future strategy for Indo – US…